Evidence-based common sense?;Bon sens fondé sur des données probantes?

Canadian Family Physician

Volumn 54, Issue 2, 2008, Pages

  Sherman, Mark ^a,b  

^a Community Health Cooperative of Victoria Initiative ^*

^b James Bay Community Project   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE MEDICINE; CLINICAL DECISION MAKING; CLINICAL PRACTICE; EVIDENCE BASED PRACTICE; HEALTH PRACTITIONER; MEDICAL EDUCATION; MEDICAL LITERATURE; NOTE; PATHOPHYSIOLOGY; PATIENT CARE; TRAINING;

CLINICAL COMPETENCE; COMPLEMENTARY THERAPIES; DECISION MAKING; EVIDENCE-BASED MEDICINE; HUMANS;

EID: 39649085081     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (17)

1. Marchevsky D. Critical appraisal of medical literature. New York, NY: Kluwer Academic/Plenum Publishers; 2000.
2. Amieva MR. Important bacterial gastrointestinal pathogens in children: a pathogenesis perspective. Pediatr Clin North Am 2005;52(3):749-77, vi.
3. Gologan A, Graham DY, Sepulveda AR. Molecular markers in Helicobacter pylori-associated gastric carcinogenesis. Clin Lab Med 2005;25(1):197-222.
4. Cunningham R, Dale B, Undy B, Gaunt N. Proton pump inhibitors as a risk factor for Clostridium difficile diarrhea. J Hosp Infect 2003;54(3):243-5.
5. Yearsley KA, Gilby LJ, Ramadas AV, Kubiak EM, Fone DL, Allison MC. Proton pump inhibitor therapy is a risk factor for Clostridium difficile-associated diarrhea. Aliment Pharmaco Ther 2006;24(4):613-9.
6. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998;280:605-13.
7. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33.
8. Colditz GA, Hankinson SE, Hunter DJ, Willett WC, Manson JE, Stampfer MJ, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 1995;332:1589-93.
9. Rossouw JE, Prentice RL, Manson JE, Wu L, Barad D, et al. Post menopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007;297:1465-77.
10. Therapeutics Initiative. COX-2 inhibitors update: do journal publications tell the full story? Ther Lett 2002;43:1-2.
11. Salmi HA, Sarna S. Effect of silymarin on chemical, functional and morphological alterations of the liver. A double-blind controlled study. Scand J Gastroenterol 1982;17:517-21.
12. Pittler MH, Schmidt K, Ernst E. Hawthorn extract for treating chronic heart failure: meta-analysis of randomized trials. Am J Med 2003;114(8):665-74.
13. Le Bars PL, Katz MM, Berman N, Itil TM, Freedman AM, Schatzberg AF. A placebo-controlled, double-blinded randomized trial of an extract of Ginkgo biloba for dementia. JAMA 1997;278:1327-32.
14. Kiefer D, Pantuso T. Panax ginseng. Am Fam Physician 2003;68:1539-42.
15. World Health Organization. Acupuncture: review and analysis of reports on controlled clinical trials. Geneva, Switz: World Health Organization; 2002.
16. Patel G. Complementary and alternative medicine for non-cancer pain. Med Clin North Am 2007;91(1):141-67.
17. Schneider RH. Long-term effects of stress reduction on mortality in persons >55 years of age with systemic hypertension. Am J Cardiol 2005;95(9):1060-4.